Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309654514> ?p ?o ?g. }
- W4309654514 endingPage "G77" @default.
- W4309654514 startingPage "G60" @default.
- W4309654514 abstract "Primary sclerosing cholangitis (PSC) is characterized by increased ductular reaction (DR), liver fibrosis, hepatic total bile acid (TBA) levels, and mast cell (MC) infiltration. Apical sodium BA transporter (ASBT) expression increases in cholestasis, and ileal inhibition reduces PSC phenotypes. FVB/NJ and multidrug-resistant 2 knockout (Mdr2-/-) mice were treated with control or ASBT Vivo-Morpholino (VM). We measured 1) ASBT expression and MC presence in liver/ileum; 2) liver damage/DR; 3) hepatic fibrosis/inflammation; 4) biliary inflammation/histamine serum content; and 5) gut barrier integrity/hepatic bacterial translocation. TBA/BA composition was measured in cholangiocyte/hepatocyte supernatants, intestine, liver, serum, and feces. Shotgun analysis was performed to ascertain microbiome changes. In vitro, cholangiocytes were treated with BAs ± ASBT VM, and histamine content and farnesoid X receptor (FXR) signaling were determined. Treated cholangiocytes were cocultured with MCs, and FXR signaling, inflammation, and MC activation were measured. Human patients were evaluated for ASBT/MC expression and histamine/TBA content in bile. Control patient- and PSC patient-derived three-dimensional (3-D) organoids were generated; ASBT, chymase, histamine, and fibroblast growth factor-19 (FGF19) were evaluated. ASBT VM in Mdr2-/- mice decreased 1) biliary ASBT expression, 2) PSC phenotypes, 3) hepatic TBA, and 4) gut barrier integrity compared with control. We found alterations between wild-type (WT) and Mdr2-/- mouse microbiome, and ASBT/MC and bile histamine content increased in cholestatic patients. BA-stimulated cholangiocytes increased MC activation/FXR signaling via ASBT, and human PSC-derived 3-D organoids secrete histamine/FGF19. Inhibition of hepatic ASBT ameliorates cholestatic phenotypes by reducing cholehepatic BA signaling, biliary inflammation, and histamine levels. ASBT regulation of hepatic BA signaling offers a therapeutic avenue for PSC.NEW & NOTEWORTHY We evaluated knockdown of the apical sodium bile acid transporter (ASBT) using Vivo-Morpholino in Mdr2KO mice. ASBT inhibition decreases primary sclerosing cholangitis (PSC) pathogenesis by reducing hepatic mast cell infiltration, altering bile acid species/cholehepatic shunt, and regulating gut inflammation/dysbiosis. Since a large cohort of PSC patients present with IBD, this study is clinically important. We validated findings in human PSC and PSC-IBD along with studies in novel human 3-D organoids formed from human PSC livers." @default.
- W4309654514 created "2022-11-29" @default.
- W4309654514 creator A5004402528 @default.
- W4309654514 creator A5010916787 @default.
- W4309654514 creator A5018460898 @default.
- W4309654514 creator A5019298056 @default.
- W4309654514 creator A5023214461 @default.
- W4309654514 creator A5027095830 @default.
- W4309654514 creator A5029205234 @default.
- W4309654514 creator A5030400303 @default.
- W4309654514 creator A5034955754 @default.
- W4309654514 creator A5045703051 @default.
- W4309654514 creator A5046002870 @default.
- W4309654514 creator A5047135599 @default.
- W4309654514 creator A5051838909 @default.
- W4309654514 creator A5055423864 @default.
- W4309654514 creator A5059963876 @default.
- W4309654514 creator A5071399872 @default.
- W4309654514 creator A5071497962 @default.
- W4309654514 creator A5071582425 @default.
- W4309654514 creator A5081117163 @default.
- W4309654514 creator A5083216612 @default.
- W4309654514 date "2023-01-01" @default.
- W4309654514 modified "2023-09-30" @default.
- W4309654514 title "Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis" @default.
- W4309654514 cites W1495796221 @default.
- W4309654514 cites W1514132913 @default.
- W4309654514 cites W1540556705 @default.
- W4309654514 cites W1554164117 @default.
- W4309654514 cites W1836306145 @default.
- W4309654514 cites W1959879255 @default.
- W4309654514 cites W1969051655 @default.
- W4309654514 cites W1975624789 @default.
- W4309654514 cites W1976321601 @default.
- W4309654514 cites W2004367786 @default.
- W4309654514 cites W2018999493 @default.
- W4309654514 cites W2035367704 @default.
- W4309654514 cites W2036843343 @default.
- W4309654514 cites W2044686871 @default.
- W4309654514 cites W2061554663 @default.
- W4309654514 cites W2064216898 @default.
- W4309654514 cites W2071879560 @default.
- W4309654514 cites W2078771263 @default.
- W4309654514 cites W2082671505 @default.
- W4309654514 cites W2082945720 @default.
- W4309654514 cites W2093795546 @default.
- W4309654514 cites W2117851005 @default.
- W4309654514 cites W2124288445 @default.
- W4309654514 cites W2132373502 @default.
- W4309654514 cites W2134897177 @default.
- W4309654514 cites W2150667457 @default.
- W4309654514 cites W2160864720 @default.
- W4309654514 cites W2328023807 @default.
- W4309654514 cites W2344596252 @default.
- W4309654514 cites W2404355916 @default.
- W4309654514 cites W2408052000 @default.
- W4309654514 cites W2474201228 @default.
- W4309654514 cites W2523163592 @default.
- W4309654514 cites W2593604375 @default.
- W4309654514 cites W2735896722 @default.
- W4309654514 cites W2745107259 @default.
- W4309654514 cites W2766754487 @default.
- W4309654514 cites W2795208237 @default.
- W4309654514 cites W2797871134 @default.
- W4309654514 cites W2806116198 @default.
- W4309654514 cites W2883359071 @default.
- W4309654514 cites W2887592114 @default.
- W4309654514 cites W2888518340 @default.
- W4309654514 cites W2899739634 @default.
- W4309654514 cites W2899957708 @default.
- W4309654514 cites W2901325363 @default.
- W4309654514 cites W2902881039 @default.
- W4309654514 cites W2909724008 @default.
- W4309654514 cites W2912286418 @default.
- W4309654514 cites W2926977525 @default.
- W4309654514 cites W2951076599 @default.
- W4309654514 cites W2951485248 @default.
- W4309654514 cites W2972401327 @default.
- W4309654514 cites W2972710502 @default.
- W4309654514 cites W2981241597 @default.
- W4309654514 cites W2995563604 @default.
- W4309654514 cites W2997448008 @default.
- W4309654514 cites W3006195412 @default.
- W4309654514 cites W3008153711 @default.
- W4309654514 cites W3009944537 @default.
- W4309654514 cites W3047549841 @default.
- W4309654514 cites W3092819530 @default.
- W4309654514 cites W3155646953 @default.
- W4309654514 cites W3176583447 @default.
- W4309654514 cites W3176705032 @default.
- W4309654514 cites W3200272914 @default.
- W4309654514 doi "https://doi.org/10.1152/ajpgi.00112.2022" @default.
- W4309654514 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36410025" @default.
- W4309654514 hasPublicationYear "2023" @default.
- W4309654514 type Work @default.
- W4309654514 citedByCount "0" @default.
- W4309654514 crossrefType "journal-article" @default.
- W4309654514 hasAuthorship W4309654514A5004402528 @default.